APLI:CC

Quote

Short

News

Articles

Message Board

Appili Therapeutics Inc. (TSXC : APLI:CC ) News

Appili Therapeutics Inc. (TSXC: APLI:CC) News Releases

APLI:CC News Releases

March 30, 2026 07:19:36 am

GlobeNewswire

Appili Therapeutics to Exhibit at World Vaccine Congress Washington

March 19, 2026 10:00:34 am

QM Canadian Market Movers

Canadian Companies Moving the Markets, Morning edition
Thu, Mar 19, 2026 as of 10.00 am ET

March 17, 2026 10:00:30 am

QM Canadian Market Movers

Canadian Companies Moving the Markets, Morning edition
Tue, Mar 17, 2026 as of 10.00 am ET

February 18, 2026 07:19:29 am

GlobeNewswire

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

February 12, 2026 06:15:44 pm

GlobeNewswire

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

December 18, 2025 07:31:16 am

GlobeNewswire

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

December 15, 2025 10:30:00 am

GlobeNewswire

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID

November 13, 2025 05:21:13 pm

GlobeNewswire

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

November 12, 2025 03:54:23 pm

GlobeNewswire

The Lundquist Institute and Its Start-Up Company Vitalex Biosciences Announce Strategic Advancement of Second-Generation Fungal Vaccine VXV-01 Through Phase 1 Trials Under $40 Million Competitive Contract From NIH/NIAID

November 05, 2025 07:16:21 am

GlobeNewswire

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account